The global Shrimps Disease Diagnostics Market is poised for rapid expansion, with market value projected to increase from USD 268.4 million in 2025 to USD 783.0 million by 2035, according to the latest industry forecast. This growth represents a robust compound annual growth rate (CAGR) of 11.3%, fueled by rising aquaculture production, increasing disease outbreaks, and technological innovation in rapid testing solutions.
Market Drivers and Industry Outlook
The shrimp industry remains one of the fastest-growing segments of global aquaculture, with shrimp serving as a primary protein source across Asia, North America, and Europe. However, disease outbreaks—particularly viral and bacterial infections—have created significant challenges for producers, leading to billions in losses annually.
“Accurate and early disease detection has become a critical factor in ensuring sustainable shrimp farming,” noted an industry analyst. “With no therapeutic solutions available for viral shrimp diseases, diagnostics remain the first and most effective line of defense.”
Click Here for More Information:- https://www.futuremarketinsights.com/reports/shrimps-disease-diagnostics-market
Key factors accelerating market growth include:
- Rising shrimp consumption worldwide as a high-value protein source.
- Intensified aquaculture practices in Asia-Pacific, particularly in India, China, and Indonesia, where 30% of farmed shrimp is produced.
- Advancements in molecular diagnostics, including DNA-based PCR assays and rapid test kits, offering farmers faster and more precise detection.
- Government emphasis on sustainable aquaculture and stricter food safety regulations in the U.S., Japan, and the EU.
Segment Insights: WSSV and Fisheries Lead Growth
The White Spot Syndrome Virus (WSSV) segment is expected to dominate with 31.8% market share in 2025. As one of the most contagious shrimp viruses, WSSV continues to threaten global supply chains, making diagnostics critical for trade compliance and farm-level biosecurity.
By application, the Fisheries segment is projected to account for 42.6% of market revenue in 2025. Fisheries operations are increasingly integrating advanced testing kits into routine stock management, enhancing early detection and minimizing mass mortality risks.
Regional Outlook: Asia-Pacific at the Forefront
The Asia-Pacific region is anticipated to lead the shrimp disease diagnostics market due to high shrimp production and export activities. Countries such as India, China, and Indonesia are key growth drivers, with government-supported aquaculture initiatives boosting adoption of diagnostic tools.
Meanwhile, North America and Europe are expected to witness steady growth, supported by stringent food safety policies and rising consumer demand for sustainably farmed shrimp.
Competitive Landscape and Benchmarking
The shrimp disease diagnostics market is moderately fragmented, with global leaders and regional innovators driving competition. Key players include:
- HiMedia Laboratories
- Speedy Assay Sdn Bhd
- REAGEN LLC
- FUJIKURA KASEI CO.
- GeneReach Biotechnology Corp.
- Thermo Fisher Scientific
- Lab-Ind Resource Sdn Bhd
- SUREBIO
- Auro Biotechnologies
Notably, Thermo Fisher Scientific continues to expand its footprint, highlighted by its 2024 acquisition of PPD for USD 241.2 billion, strengthening its R&D and diagnostics portfolio. Competitors such as GeneReach Biotechnology and HiMedia are focusing on assay-based rapid kits, enabling cost-effective diagnostics for small and medium-scale fisheries.
Industry Trends and Future Outlook
The coming decade is expected to see heightened adoption of DNA-based diagnostic tools, improved point-of-care testing, and digital surveillance platforms for shrimp health management. Integration of AI and big data analytics into aquaculture monitoring is also emerging as a competitive differentiator, offering predictive insights to mitigate disease outbreaks before they occur.
“Shrimp farming is at a crossroads—balancing rising demand with the urgent need for disease control and sustainable practices,” added the analyst. “Diagnostics will not only safeguard production but also serve as a benchmark for global food security and trade compliance.”
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-9922
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
